±³Åë ¹× ¼÷¹Ú¾È³»

ŸÀÌƲ

2012³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°è Çмú´ëȸ ¹× ¿¬¼ö°­Á Program

rooma   roomb        

8/31(±Ý)
13:00 °³È¸¼±¾ð Ãæ³²ÀÇ´ë º´¸®Çб³½Ç °­´ë¿µ(´ëȸÀå)
13:00-13:20 Ûíߣ ÍÔóãâï ±³¼ö Ã߸ðÇà»ç  
13:20-14:50 Oral Presentation A ÁÂÀå: ¿¬¼¼ÀÇ´ë ³»°ú ÀÌÀºÁ÷/
      °í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú ÀÌ°­´ë
13:20-14:50 Oral Presentation B ÁÂÀå: ¿ï»êÀÇ´ë ¿µ»óÀÇÇаú ¹éÁ¤È¯ /
      ¼º±Õ°üÀÇ´ë ¿Ü°ú ±èÁö¼ö
14:50-15:00 Coffee break  
15:00-16:30 Symposium A: Anaplastic thyroid cancer (¿µ¾î·Î ÁøÇà) ÁÂÀå: ¿¬¼¼ÀÇ´ë ³»°ú ±è°æ·¡ /
      °¡ÃµÀÇ´ë ¿Ü°ú ÀÌ¿µµ·
  Anaplastic thyroid cancer: a therapeutic dilemma Hang-Seok Chang(Yonsei Univ. Korea)
  Novel treatment for anaplastic cancer with conventional drugs Hitoshi Noguchi
(Noguchi Thyroid Clinic and
Hospital Foundation, Beppu, Japan)
  Anaplastic thyroid cancer: a UK perspective Jonathan Wadsley
(Weston Park Hospital, UK)
15:00-16:30 Symposium B: Dosimetric approach in radioactive iodine treatment ÁÂÀå: Àü³²ÀÇ´ë ÇÙÀÇÇаú ¹üÈñ½Â /
      ÃæºÏÀÇ´ë ³»°ú ±Ã¼º¼ö
  Rationale of conventional fixed dose in radioiodine therapy ¼øõÇâÀÇ´ë ÇÙÀÇÇаú ¹ÚÁ¤¹Ì
  Image based dosimetric evaluation of radionuclide therapy Çѱ¹¿øÀÚ·ÂÀÇÇпø ÇÙÀÇÇаú ÀÓÀÏÇÑ
  Radioiodine therapy based on dosimetric approach: method and efficacy ¼­¿ïÀÇ´ë ÇÙÀÇÇаú ÆØÁøö
16:30-16:50 ¹æ»ç¼º ¿ä¿Àµå Ä¡·á¿Í °ü·ÃµÈ ȯÀÚ ±³À°ÀÚ·á Á¦Á¤ º¸°í ¿ï»êÀÇ´ë ³»°ú ±è¿ø¹è
16:50-18:20 ¿¬±¸ À§¿øȸ Seminar: È¿°úÀûÀÎ ÇÁ·¹Á¨Å×À̼ǹý ¿ï»êÀÇ´ë À̺ñÀÎÈÄ°ú ÃÖ½ÂÈ£
  Prezi¸¦ ÀÌ¿ëÇÑ story telling ±¤Áֱ⵶º´¿ø À̺ñÀÎÈÄ°ú ¹Úº´Ã¶
  ½º¸¶Æ®-¿öÅ© ½Ã´ëÀÇ ÇÁ·¹Á¨Å×ÀÌ¼Ç µðÀÚÀÎ MS powerpoint MVP ±èÁöÈÆ
16:50-18:20 ¹æ»ç¼º ¿ä¿Àµå Ä¡·á ȯÀÚÀÇ ±³À° (½Ç¹«ÀÚ¸¦ À§ÇÑ ±³À°) ÁÂÀå: ¿ï»êÀÇ´ë ³»°ú ±è¿ø¹è
  ¹æ»ç¼º ¿ä¿Àµå Ä¡·áÀÇ °³°ü°ú Ä¡·á¸¦ À§ÇÑ Áغñ »çÇ× ¼­¿ïÀÇ´ë ³»°ú ¹Ú¿µÁÖ
  ¹æ»ç¼º ¿ä¿Àµå Ä¡·á½Ã ¹× Ä¡·á ÈÄ °ü¸® Áß¾ÓÀÇ´ë ÇÙÀÇÇаú ¼®ÁÖ¿ø
  ¹æ»ç¼º ¿ä¿Àµå Ä¡·á¸¦ À§ÇÑ Àú¿ä¿Àµå ½Ä»ç¿ä¹ý °­³²¼¼ºê¶õ½ºº´¿ø ¿µ¾çÆÀ À̼۹Ì
  ¹æ»ç¼º ¿ä¿Àµå Ä¡·á ȯÀÚ ±³À°ÀÇ ½ÇÁ¦ ¼­¿ï¾Æ»êº´¿ø ÇÙÀÇÇаú CNS À¯¼±Èñ
9/1(Åä)
08:00-9:30 Oral Presentation C ÁÂÀå: °¡Å縯ÀÇ´ë À̺ñÀÎÈÄ°ú ±è¹Î½Ä /
      ºÎ»êÀÇ´ë ³»°ú ±èÀÎÁÖ
08:00-9:30 Oral Presentation D ÁÂÀå: ¿¬¼¼ÀÇ´ë ¿Ü°ú Á¤¿õÀ± /
      °í½ÅÀÇ´ë ³»°ú ÃÖ¿µ½Ä
09:30-10:20 Plenary lecture: ÁÂÀå: ¿¬¼¼¿øÁÖÀÇ´ë ¿Ü°ú °­¼ºÁØ
      (´ëÇÑ°©»ó¼±ÇÐȸ ȸÀå)
  Noguchi Thyroid Clinic: 90 years of thyroid surgery and beyond Hitoshi Noguchi
(Noguchi Thyroid Clinic and
Hospital Foundation, Beppu, Japan)
10:20-10:30 Coffee break  
10:30-12:00 Symposium C - Controversies in staging system ÁÂÀå: ¿¬¼¼ÀÇ´ë º´¸®°ú È«¼ø¿ø /
      °¡Å縯´ë ¿Ü°ú ±èÁ¤¼ö
  Overview of staging system in thyroid cancer ¿ï»êÀÇ´ë ¿Ü°ú Á¤±â¿í
  T stage: controversies and recent issues °æºÏÀÇ´ë º´¸®°ú ¹ÚÁö¿µ
  N stage: controversies and recent issues ¼­¿ïÀÇ´ë º´¸®°ú ¹ÎÇý¼÷
10:30-12:00 Symposium D - Molecular biology update in thyroidology ÁÂÀå: ¼­¿ïÀÇ´ë ³»°ú ¹ÚµµÁØ /
      Ãæ³²ÀÇ´ë ³»°ú ¼Û¹ÎÈ£
  HIF-1 alpha¿Í Á¶Á÷Àú»ê¼ÒÁõ ¿¬¼¼ÀÇ´ë À̺ñÀÎÈÄ°ú °íÀ±¿ì
  L1 ¼¼Æ÷ºÎÂø¹°Áú°ú ¾ÏÀÇ Áõ½Ä, À̵¿, ÀüÀÌ Ãæ³²ÀÇ´ë ³»°ú ±è±º¼ø
  ¸é¿ª¼¼Æ÷¿Í ¾Ï¼¼Æ÷ÀÇ »óÈ£ÀÛ¿ë ¼­¿ïÀÇ´ë ³»°ú Á¶¼±¿í
12:00-12:20 ÃÑȸ  
12:20-13:30 Lunch  
13:30-13:20 Special Lecture ÁÂÀå: ¼º±Õ°üÀÇ´ë ³»°ú Á¤ÀçÈÆ
      (´ëÇÑ°©»ó¼±ÇÐȸ ÀÌ»çÀå)
  Multicentre randomized phase III clinical trial of high vs. low dose radioiodine, with or without recombinant human thyroid stimulating hormone (rhTSH), for remnant ablation for differentiated thyroid cancer: results of
the HiLo trial.
Jonathan Wadsley(Consultant Clinical Oncologist, Sheffield Teaching Hospitals NHS Trust, Weston Park Hospital, UK)
14:20-15:20 Topic Highlights ÁÂÀå: °¡Å縯ÀÇ´ë ³»°ú À̱¤¿ì /
      ¼­¿ïÀÇ´ë ¿Ü°ú À±¿©±Ô
15:20-15:30 Coffee break  
15:30-16:00 Presidential Lecture ÁÂÀå: °¡Å縯ÀÇ´ë ³»°ú À̱¤¿ì
    ¿¬¼¼¿øÁÖÀÇ´ë °­¼ºÁØ
(´ëÇÑ°©»ó¼±ÇÐȸ ȸÀå)
16:00-17:40 Panel discussion: ÁÂÀå: ¿¬¼¼ÀÇ´ë ¿Ü°ú ¹ÚÁ¤¼ö
  ¾ÖÁ¤ÇÐ(¾Ö¸ÅÇÑ °ÍÀ» Á¤¸®ÇØÁÖ´Â ÇÐȸ) Panel: ¼Û¿µ±â(¿ï»êÀÇ´ë ³»°ú),
       ¼ÒÀÇ¿µ(¾ÆÁÖÀÇ´ë ¿Ü°ú),
       Á¤±¤À±(°í·ÁÀÇ´ë À̺ñÀÎÈÄ°ú),
       Á¤Áرâ(¼­¿ïÀÇ´ë ÇÙÀÇÇаú ),
       ³ªµ¿±Ô(ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ),
       È«¼ø¿ø(¿¬¼¼ÀÇ´ë º´¸®°ú)
17:40-18:00 ½Ã»ó½Ä ¹× Æóȸ  
9/1(Åä) ¿¬¼ö°­ÁÂ
18:00-18:30 µî·Ï ¹× °³È¸»ç  
18:30-19:45 Á¦1ºÎ °©»ó¼± ±â´É¼ºÁúȯ ÁÂÀå: ´ëÀü½Ã °³¿ø³»°ú ºÎȸÀå Ȳ¿¬Èñ
  1. ¿À·ù ¾øÀÌ °©»ó¼±±â´É°Ë»ç¸¦ Çؼ®ÇÏ´Â ¹ý ¿ï»ê´ëº´¿ø ±èÀº¼÷
  2. °©»ó¼±±â´ÉÇ×ÁøÁõ »õ·Î¿î Áø·á Áöħ ¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø ÀÌ°¡Èñ
  3. °©»ó¼±ÀúÇÏÁõ Ä¡·á Á¦´ë·Î Çϱ⠴ëÀü¼º¸ðº´¿ø ÀÌÁ¾¹Î
19:45~20:00 Coffee break  
20:00-21:15 Á¦2ºÎ °©»ó¼± °áÀý°ú ¾Ï ÁÂÀå: »õ¼­¿ï³»°ú À̱â»ó
  1. °©»ó¼±¾Ï ¼ö¼ú ÈÄ °æºÎ ÃÊÀ½ÆÄ: ¹«¾ùÀ» ¾î¶»°Ô ºÁ¾ß Çϳª ¼­¿ï¼º¸ðº´¿ø Á¤¼Ò·É
  2. °©»ó¼±ÃÊÀ½ÆÄ ¹× ¹Ì¼¼Ä§ÈíÀμ¼Æ÷°Ë»çÀÇ ½ÇÁ¦ È­¼øÀü³²´ëº´¿ø ±èÈñ°æ
  3. ÀÓ»óÀÇ°¡ ¾Ë¾Æ¾ß ÇÒ °©»ó¼± ¼¼Æ÷º´¸®°Ë»çÀÇ Çؼ® Á߾Ӵ뺴¿ø Á¤À±Àç

Copyright ¨Ï 2008 Korean Thyroid Association. All rights reserved.
¼­¿ï½Ã °­³²±¸ ÀÏ¿ø·Î 81 »ï¼º¼­¿ïº´¿ø º°°ü 8Ãþ ³»ºÐºñ´ë»ç³»°ú(³») ´ëÇÑ°©»ó¼±ÇÐȸ»ç¹«±¹
Tel: 070-7528-3691 / Fax : 02-6918-4246 / E-mail : kta@chol.com